RapidAI

RapidAI is a healthcare technology company using artificial intelligence to improve the diagnosis and treatment of life-threatening vascular and neurovascular conditions. Its technology helps physicians make faster, more informed clinical decisions while improving patient workflows and care coordination.

At the center of RapidAI's offering is the Rapid® platform, which uses AI to analyze medical imaging and provide care teams with timely insights into patients with serious vascular and neurovascular conditions. By improving visibility across the care journey, the platform helps clinicians identify critical cases, coordinate treatment, and make time-sensitive decisions more efficiently.

RapidAI's technology is informed by intelligence derived from more than 10 million scans across over 2,000 hospitals in more than 60 countries. This global scale of clinical data supports the company's efforts to advance AI-powered clinical decision-making and improve access to timely, high-quality care.

By combining artificial intelligence, medical imaging, and care coordination technology, RapidAI helps healthcare providers move faster when every minute matters, supporting better workflows and ultimately improving patient outcomes.